Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance.

Åbacka H., Hansen JS., Huang P., Venskutonytė R., Hyrenius-Wittsten A., Poli G., Tuccinardi T., Granchi C., Minutolo F., Hagström-Andersson AK., Lindkvist-Petersson K.

DOI

10.3324/haematol.2020.246843

Type

Journal article

Journal

Haematologica

Publication Date

01/04/2021

Volume

106

Pages

1163 - 1166

Keywords

Antimetabolites, Antineoplastic, Antineoplastic Combined Chemotherapy Protocols, Cytarabine, Glucose Transporter Type 1, Humans, Leukemia, Myeloid, Acute

Permalink Original publication